Is Quinapril registered with the SFDA?

The SFDA human drug list (edition 4-2026, as published by the Council of Health Insurance) lists 0 valid registrations of Quinapril.

Is Quinapril approved by the US FDA?

Drugs@FDA lists 14 application product lines for Quinapril, including QUINAPRIL HYDROCHLORIDE (Prescription); QUINAPRIL HYDROCHLORIDE (Prescription); QUINAPRIL HYDROCHLORIDE (Prescription); QUINAPRIL HYDROCHLORIDE (Prescription); ACCUPRIL (Discontinued).

Are there safety signals or safety updates for Quinapril?

US FDA: 2 entries (latest 2021-02-19).

Active substance

Quinapril

SFDA 2
US FDA 14
Health Canada 6
Safety 2

Open in the medicines table

SFDA Saudi Arabia — SFDA human drug list

Trade name	Strength	Form · route	Pack	Public price	Type	Company	Status
ACUITEL 10MG TAB	10 mg	Film-coated tablet · Oral use	30 Blister	SAR 9.50	NCE · Prescription	PFIZER	Withdrawn by MAH · Not Marketed
ACUITEL 20MG TAB	20 mg	Film-coated tablet · Oral use	30 Blister	SAR 19.05	NCE · Prescription	PFIZER	Withdrawn by MAH · Not Marketed

US FDA United States — FDA approvals (Drugs@FDA)

Product	Strength	Form · route	Applicant	Status	First approved
QUINAPRIL HYDROCHLORIDE	EQ 5MG BASE; EQ 10MG BASE; EQ 20MG BASE; EQ 40MG BASE	tablet · oral	CHARTWELL RX	Prescription	2 Mar 2005
QUINAPRIL HYDROCHLORIDE	EQ 5MG BASE; EQ 10MG BASE; EQ 20MG BASE; EQ 40MG BASE	tablet · oral	LUPIN	Prescription	20 Jun 2006
QUINAPRIL HYDROCHLORIDE	EQ 5MG BASE; EQ 10MG BASE; EQ 20MG BASE; EQ 40MG BASE	tablet · oral	AUROBINDO PHARMA LTD	Prescription	29 Apr 2013
QUINAPRIL HYDROCHLORIDE	EQ 5MG BASE; EQ 10MG BASE; EQ 20MG BASE; EQ 40MG BASE	tablet · oral	PRINSTON INC	Prescription	15 Sep 2016
ACCUPRIL	EQ 5MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons; EQ 10MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons; EQ 20MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons; EQ 40MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	tablet · oral	PFIZER PHARMS	Discontinued	19 Nov 1991
QUINAPRIL HYDROCHLORIDE	EQ 5MG BASE; EQ 10MG BASE; EQ 20MG BASE; EQ 40MG BASE	tablet · oral	SUN PHARM INDS LTD	Discontinued	15 Dec 2004
QUINAPRIL HYDROCHLORIDE	EQ 5MG BASE; EQ 10MG BASE; EQ 20MG BASE; EQ 40MG BASE	tablet · oral	ACTAVIS ELIZABETH	Discontinued	22 Dec 2004
QUINAPRIL HYDROCHLORIDE	EQ 5MG BASE; EQ 10MG BASE; EQ 20MG BASE; EQ 40MG BASE	tablet · oral	PHARMOBEDIENT	Discontinued	23 Dec 2004
QUINAPRIL HYDROCHLORIDE	EQ 5MG BASE; EQ 10MG BASE; EQ 20MG BASE; EQ 40MG BASE	tablet · oral	ACTAVIS LABS FL INC	Discontinued	14 Jan 2005
QUINAPRIL HYDROCHLORIDE	EQ 5MG BASE; EQ 10MG BASE; EQ 20MG BASE; EQ 40MG BASE	tablet · oral	APOTEX INC	Discontinued	26 Jan 2006
QUINAPRIL HYDROCHLORIDE	EQ 5MG BASE; EQ 10MG BASE; EQ 20MG BASE; EQ 40MG BASE	tablet · oral	ANI PHARMS	Discontinued	24 Aug 2007
QUINAPRIL HYDROCHLORIDE	EQ 5MG BASE; EQ 10MG BASE; EQ 20MG BASE; EQ 40MG BASE	tablet · oral	INVAGEN PHARMS	Discontinued	24 Aug 2007
QUINAPRIL HYDROCHLORIDE	EQ 5MG BASE; EQ 10MG BASE; EQ 20MG BASE; EQ 40MG BASE	tablet · oral	SUN PHARM INDS LTD	Discontinued	18 Jun 2009
QUINAPRIL HYDROCHLORIDE	EQ 5MG BASE; EQ 10MG BASE; EQ 20MG BASE; EQ 40MG BASE	tablet · oral	MYLAN	Discontinued

Canada Canada — marketed products (Health Canada)

Brand	DIN	Strength	Form · route	Company
JAMP QUINAPRIL	02517450	10 MG	TABLET · ORAL	JAMP PHARMA CORPORATION
JAMP QUINAPRIL	02517469	20 MG	TABLET · ORAL	JAMP PHARMA CORPORATION
JAMP QUINAPRIL	02517477	40 MG	TABLET · ORAL	JAMP PHARMA CORPORATION
PMS-QUINAPRIL	02340569	10 MG	TABLET · ORAL	PHARMASCIENCE INC
PMS-QUINAPRIL	02340577	20 MG	TABLET · ORAL	PHARMASCIENCE INC
PMS-QUINAPRIL	02340585	40 MG	TABLET · ORAL	PHARMASCIENCE INC

Safety signals and safety-related labeling changes

US FDA 19 Feb 2021 ACCURETIC — safety-related labeling change
Labeling sections changed: Contraindications; Warnings and Precautions; Adverse Reactions
US FDA 26 Apr 2017 ACCUPRIL — safety-related labeling change
Labeling sections changed: Contraindications; Warnings and Precautions; Adverse Reactions

All safety entries for quinapril →

Combinations containing Quinapril

Hydrochlorothiazide + quinapril

Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.